Clinical Trial Update: Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• cinacalcet (cinacalcet hydrochloride)

Snippet

Sponsor: Papageorgiou General Hospital | Conditions: Secondary Hyperparathyroidism | Phase 4 | Status: TERMINATED